Redwood Pharma initiates toxicological safety studies
March 15, 2017 12:00 pmRedwood Pharma AB (publ) now begins toxicological safety studies for its drug development project RP101. The results will initially be... View Article
Categories for News
New US patent approved
March 2, 2017 12:00 pmRedwood Pharma’s licensor, Broda Technologies, has been granted an additional patent in the US regarding the IntelliGel drug delivery platform.... View Article
Redwood Pharma AB (publ) End of Year Report 2016
February 15, 2017 12:00 pmRedwood Pharma AB (publ), End of Year Report 2016 January – December 2016. The period January 1 – December 31,... View Article
Eye expert to support Redwood Pharma
February 13, 2017 12:00 pmIn preparation for the upcoming pharmaceutical clinical trial of RP101, Redwood Pharma AB (publ) has retained Associate Professor Gerhard Garhöfer... View Article
Redwood Pharma has developed a process for manufacture of the drug RP101 for coming safety studies
January 16, 2017 12:00 pmJanuary 16, 2017, Stockholm: Redwood Pharma AB (publ) has now according to plan completed optimization work surrounding the manufacturing process... View Article
Development of Redwood Pharma’s RP101 ophthalmic therapy continues according to plan along with value-enhancing networking
December 21, 2016 12:00 pmThe pace of Redwood Pharma development activities surrounding the company’s dry eye ophthalmic therapy RP101 has been high during the... View Article
Redwood Pharma AB (publ) to present at Aktiespararna conference in Örebro on November 19, 2016
November 8, 2016 12:00 pmOn Saturday, November 19 Redwood Pharma AB will present at the conference ”Inspirationsträff för tjejer – Våga spara i aktier!”... View Article
Redwood Pharmas IntelliGel drug delivery platform demonstrates positive results in in vitro test
October 7, 2016 12:00 pmRedwood Pharma’s RP101 ophthalmic drug development therapy uses the IntelliGel drug delivery platform. It has now been tested in an... View Article
Redwood Pharma AB appoints Ulf Björklund as Chief Medical Officer
September 20, 2016 12:00 pmRedwood Pharma AB (publ), a company that develops pharmaceuticals within ophthalmology, announces today that Ulf Björklund has accepted the company’s... View Article
Market Trends Highlighted in Tear Film and Ocular Surface (TFOS) Conference in Montpellier Confirm Need for Redwood Pharmas Dry Eye Therapy
September 16, 2016 12:00 pmWomen make up two thirds of those suffering from Dry Eye Disease (DED). Presentations and scientific results shown at TFOS,... View Article